Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy

NCT01679119

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stoke Mandeville Hospital (including Wycombe Hospital) Aylesbury, United Kingdom
  • North Hampshire Hospital Basingstoke, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
View all 40 locations
View Trial Details
Completed

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

NCT01846390

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details
Completed

Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib

NCT05068440

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat Sen University Cancer Center Guangzhou, Guangdong, China
View all 25 locations
View Trial Details
Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details
Completed

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

NCT03458260

Conditions
Aggressive Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • AZ Sint Jan Bruges, Belgium
  • Institut Jules Bordet - Centre des tumeurs de l'ULB Brussels, Belgium
  • Centre Hospitalier de Jolimont Haine-Saint-Paul, Belgium
  • CH d'Avignon Avignon, France
View all 22 locations
View Trial Details
Completed

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

NCT04282018

Conditions
Advanced Solid Tumor, Chronic Disease, Chronic Lymphocytic Leukemia, +27 more
Locations
  • Blacktown Cancer and Haematology Centre Blacktown, New South Wales, Australia
  • Saint Vincents Hospital Sydney Darlinghurst, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Gallipoli Medical Research Foundation Greenslopes, Queensland, Australia
View all 24 locations
View Trial Details

Related conditions